The Many-Faced Program of Epithelial–Mesenchymal Transition: A System Biology-Based View

System biology uses a range of experimental and statistical methods to dissect complex processes that results from alterations in biological models. Given the complexity of the epithelial–mesenchymal transition (EMT) program, system biology represents a promising approach to understanding its fine molecular regulation by the interpretation of high-throughput datasets. Herein, we review recent contributions of system biology applied to the field of EMT physiology and illustrate the importance of these approaches to model biological networks that are perturbed during the transition. Together, these results allowed the definition of an EMT signature across different tumor types, the identification of dysregulated processes and new modules of regulation, making possible to reveal the EMT molecular visage underneath.

[1]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[2]  T. Tan,et al.  Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.

[3]  Meng-zhu Xue,et al.  Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition , 2016, Nucleic acids research.

[4]  Zhifu Sun,et al.  A genetic cell context-dependent role for ZEB1 in lung cancer , 2016, Nature Communications.

[5]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[6]  O. Wolkenhauer,et al.  Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures , 2017, Nature Communications.

[7]  C. Meisinger,et al.  ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types , 2016, Nature Communications.

[8]  Srikanth S. Manda,et al.  Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells , 2017, Scientific Reports.

[9]  I. Fournier,et al.  β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells , 2017, Front. Physiol..

[10]  M Choolani,et al.  An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) , 2013, Cell Death and Disease.

[11]  Tuan Zea Tan,et al.  CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype , 2015, Oncotarget.

[12]  M. T. Pinto,et al.  Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells* , 2016, Molecular & Cellular Proteomics.

[13]  Reka Albert,et al.  Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. , 2014, Cancer research.

[14]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[15]  Erik Sahai,et al.  Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization , 2015, Cell reports.

[16]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[17]  Daniel C. Liebler,et al.  Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction* , 2016, Molecular & Cellular Proteomics.

[18]  E. Danen,et al.  Deciphering Epithelial–Mesenchymal Transition Regulatory Networks in Cancer through Computational Approaches , 2017, Front. Oncol..

[19]  Y. Qi,et al.  A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes , 2012, British Journal of Cancer.

[20]  S. Alahari,et al.  Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications , 2016, Molecular Cancer.

[21]  Aaron S. Meyer,et al.  Signaling Network State Predicts Twist-Mediated Effects on Breast Cell Migration Across Diverse Growth Factor Contexts* , 2011, Molecular & Cellular Proteomics.

[22]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[23]  Stuart Thomson,et al.  A systems view of epithelial–mesenchymal transition signaling states , 2010, Clinical & Experimental Metastasis.

[24]  Chad J Creighton,et al.  Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas , 2018, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  I. Macara,et al.  Organization and execution of the epithelial polarity programme , 2014, Nature Reviews Molecular Cell Biology.

[26]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[27]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[28]  J. Condeelis,et al.  Mechanism of early dissemination and metastasis in Her2+ mammary cancer , 2016, Nature.

[29]  M. Lai,et al.  The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis , 2017, Scientific Reports.

[30]  S. Alberti,et al.  Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells. , 2014, Journal of biotechnology.

[31]  Luc Girard,et al.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. , 2016, The Journal of clinical investigation.

[32]  Tian Hong,et al.  An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States , 2015, PLoS Comput. Biol..

[33]  Jeffrey D. Varner,et al.  Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1 , 2015, bioRxiv.

[34]  R. Aft,et al.  Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence , 2011, Molecular Cancer Research.

[35]  Jeffrey R. Whiteaker,et al.  Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.

[36]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[37]  Jan Baumbach,et al.  Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysis. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[38]  T. Kislinger,et al.  Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. , 2013, Experimental cell research.

[39]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[40]  Christian Frezza,et al.  Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival , 2016, Nature Communications.

[41]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[42]  R. Weinberg,et al.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells , 2015, Nature.

[43]  Michael Peyton,et al.  An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.

[44]  E. Dejana,et al.  The molecular basis of endothelial cell plasticity , 2017, Nature Communications.

[45]  Min Zhao,et al.  dbEMT: an epithelial-mesenchymal transition associated gene resource , 2015, Scientific Reports.

[46]  Reka Albert,et al.  Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes , 2015, npj Systems Biology and Applications.

[47]  Florence March,et al.  2016 , 2016, Affair of the Heart.

[48]  Masao Nagasaki,et al.  A Novel Network Profiling Analysis Reveals System Changes in Epithelial-Mesenchymal Transition , 2011, PloS one.

[49]  H. Hermeking,et al.  Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression , 2017, Scientific Reports.

[50]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[51]  Eshel Ben-Jacob,et al.  Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis , 2015, Scientific Reports.

[52]  Pabitra Mitra,et al.  Modeling continuum of epithelial mesenchymal transition plasticity. , 2016, Integrative biology : quantitative biosciences from nano to macro.

[53]  Jingyu Zhang,et al.  TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops , 2014, Science Signaling.

[54]  Jaime Rodriguez-Canales,et al.  A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.

[55]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.